Search results
Wall Street Analysts Think Catalyst (CPRX) Could Surge 26.44%: Read This Before Placing a Bet
Zacks via Yahoo Finance· 1 year agoThe average of price targets set by Wall Street analysts indicates a potential upside of 26.4% in...
Catalyst (CPRX) Q4 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 2 months agoCatalyst Pharmaceuticals, Inc. CPRX reported adjusted diluted earnings of 53 cents per share for the...
Is Trending Stock Catalyst Pharmaceuticals, Inc. (CPRX) a Buy Now?
Zacks via Yahoo Finance· 1 year agoCatalyst Pharmaceutical (CPRX) has recently been on Zacks.com's list of the most searched stocks....
Catalyst Pharmaceuticals (CPRX) Rallies 80.69% YTD: Here's Why
Zacks via Yahoo Finance· 2 years agoCatalyst Pharmaceuticals CPRX stock has skyrocketed 80.6% in the year-to-date period against the...
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who...
Simply Wall St. via Yahoo Finance· 1 week agoKey Insights Given the large stake in the stock by institutions, Catalyst Pharmaceuticals' stock...
Is Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Recent Stock Performance Tethered To Its Strong...
Simply Wall St. via Yahoo Finance· 4 months agoCatalyst Pharmaceuticals (NASDAQ:CPRX) has had a great run on the share market with its stock up by...
Here's Why Catalyst Pharmaceutical (CPRX) is a Great Momentum Stock to Buy
Zacks via Yahoo Finance· 2 years agoMomentum investing is all about the idea of following a stock's recent trend, which can be in either...
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Is Going Strong: Is the Market Following...
Simply Wall St. via Yahoo Finance· 2 years agoCatalyst Pharmaceuticals (NASDAQ:CPRX) has had a great run on the share market with its stock up by...
Catalyst (CPRX) Q2 Earnings & Sales Top, 2023 Outlook Raised
Zacks via Yahoo Finance· 9 months agoShares of Catalyst Pharmaceuticals, Inc. CPRX climbed 6.4% on Thursday after the company reported...
Will Weakness in Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Prove Temporary Given Strong...
Simply Wall St. via Yahoo Finance· 9 months agoWith its stock down 17% over the past three months, it is easy to disregard Catalyst Pharmaceuticals...